Form 8-K - Current report:
SEC Accession No. 0001746473-24-000153
Filing Date
2024-09-27
Accepted
2024-09-27 16:11:29
Documents
14
Period of Report
2024-09-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plrx-20240924.htm   iXBRL 8-K 30987
2 EX-3.1 THIRD AMENDED AND RESTATED BYLAWS plrx-thirdamendedandrestat.htm EX-3.1 309749
  Complete submission text file 0001746473-24-000153.txt   506659

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20240924.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20240924_lab.xml EX-101.LAB 22532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20240924_pre.xml EX-101.PRE 13045
16 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20240924_htm.xml XML 2835
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 241334971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)